Chayakulkeeree M., Naksanguan T. Epidemiology and clinical characteristic of mycobacterial infections in Human Immunodeficiency Virus-infected patients in Siriraj Hospital. Journal of the Medical Association of Thailand.
2015.
98
(3):
238-244.
Department : Department of Medicine
Journal Name : Journal of the Medical Association of Thailand
/ IF = 0.146
Source : Scopus
Cheng, A. L.; Cornelio, G. H.; Shen, L.; Price, T. J.; Yang, T. S.; Chung, I. J.; Dai, G.; Lin, J. K.; Sharma, A.; Yeh, K. H.; Ma, B.; Zaatar, A.; Guan, Z.; Masood, N.; Srimuninnimit, V.; Yau, T. C.; Beier, F.; Chatterjee, S.; Lim, R. S. C.
. Association between early tumour shrinkage and outcomes in RAS-wild type patients with metastatic colorectal cancer receiving first-line FOLFOX or FOLFIRI plus cetuximab once every 2 weeks in the APEC study
. EUROPEAN JOURNAL OF CANCER.
2015.
51
S367-S367.
Department : Medicine
Journal Name : EUROPEAN JOURNAL OF CANCER
/ IF = 5.417
Source : ISI
69.
Cheng, Ann-Lii; Cornelio, Gerardo H.; Shen, Lin; Price, Timothy Jay; Yang, Tsai-Sheng; Chung, Ilk Joo; Dai, Guanghai; Lin, Jen-Kou; Sharma, Atul; Yeh, Kun-Huei; Ma, Brigette; Zaatar, Adel; Guan, Zhongzhen; Masood, Nehal; Srimuninnimit, Vichien; Yau, Thomas Cheung; Beler, Frank; Chatterjee, Suipto; Lim, Robert S. C. Final analysis of the phase 2 APEC study: Overall survival (OS) data and biomarker subanalyses for first-line FOLFOX or FOLFIRI with cetuximab (cet) once every 2 weeks in patients (pts) with KRAS or RAS (KRAS and NRAS, exons 2-4) wild-type (wt) metastatic colorectal cancer (mCRC). JOURNAL OF CLINICAL ONCOLOGY.
2015.
33
(3):
Department : Department of Medicine
Journal Name : JOURNAL OF CLINICAL ONCOLOGY
/ IF = 18.428
Source : ISI
